Home > Drug List > Eltrombopag > News of Eltrombopag

News of Eltrombopag

Eltrombopag is the world's first small molecule non peptide thrombopoietin receptor (TPO-R) agonist approved by the US Food and Drug Administration (FDA). It was approved by the FDA in 2008 for the treatment of idiopathic thrombocytopenic purpura (ITP).

Eltrombopag, as the first approved small molecule non peptide TPO-R agonist, occupies an important position in the drug market. It, together with other similar products such as Avatrombopag and Lusutotrombopag, constitutes an important drug choice for the treatment of thrombocytopenia.

Recommended Articles

Related Articles

  • How much is a box of eltrombopa

    To explore the price of eltrombopag and its role in the treatment of specific diseases to provide a reference for patients.How much is a box of eltrombopaThe price of eltrombopag a···【more】
    Article source:Lucius LaosRelease date:2025-03-13Recommended:86

  • How much do the different versions of eltrombopag cost?

    In the healthcare sector, the price of medicines is an aspect of great concern for patients and their families.How much do the different versions of eltrombopag cost?Knowing how th···【more】
    Article source:Lucius LaosRelease date:2025-03-13Recommended:65

  • How many versions of eltrombopa are there?

    Variety and availability of medications is an important consideration for both patients and healthcare providers, as it directly impacts treatment selection and efficacy.How many v···【more】
    Article source:Lucius LaosRelease date:2025-03-12Recommended:73

  • What kind of medicine is eltrombopag?

    Eltrombopag is a drug used to treat specific blood disorders, and its clinical application has brought new hope to many patients.What kind of medicine is eltrombopag?Eltrombopag is···【more】
    Article source:Lucius LaosRelease date:2025-03-12Recommended:87

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved